Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Few Signs Of An IPO Slowdown Despite US Biotech Stock Slump

20 Nov 2018

• By Mandy Jackson

• Source: Shutterstock

Related Content

Finance Watch: With The Year's Biggest IPO, CFO Says Allogene Is Ready To Go 'Full Throttle'

12 Oct 2018

Finance Watch: VC Tally Hits $14.5bn For 2018, Beating 2017 With A Quarter Left To Go

16 Oct 2018

IPO Update: Returns Sag As Seven More Biopharmas Go Public In September

02 Oct 2018

Related Companies

Arvinas, Inc.

Allogene Therapeutics Inc.

Additional Topics

Business Strategies Financing Commercial Outlook 2019 BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.